“…Thirty-one studies met the inclusion criteria, comprising 5007 patients with OCSCC from 24 different countries. Sixteen studies were from Asia [ 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 ], eight from Europe [ 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 ], two from Africa [ 43 , 44 ], two from South America [ 35 , 45 ], two from North America [ 46 , 47 ], and one from Asian Pacific [ 48 ]. The study size ranged from 17 patients in a study from Uganda [ 44 ] to 940 patients in the Netherlands [ 41 ].…”